NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/27/2018
Back to search
Official data from USPTO
CANDEPRESSIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/15/2026
Trademark type
Word
Nice classes
5
Filing date
10/14/2006
Registration date
04/08/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/27/2018
Last transaction
05/15/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/15/2007
First use in commerce
02/01/2008
Drawing code
4
Owner type
03
Owner location
Spring Valley, NY, US
Examiner
FISHER, HANNAH
Law office
M20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
LIPTIS PHARMACEUTICALS USA, INC.
Liptis Laboratories, Inc.
Representatives
Brian A. Bloom MORITT HOCK & HAMROFF LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of hypertension
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/27/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/27/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/19/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
04/09/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/08/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/21/2014
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/10/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/10/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/10/2013
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
10/03/2013
E815
TEAS SECTION 8 & 15 RECEIVED
10/03/2013
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/25/2013
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/25/2013
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/03/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
04/08/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
03/04/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/03/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/03/2008
IUAF
USE AMENDMENT FILED
02/07/2008
EISU
TEAS STATEMENT OF USE RECEIVED
02/07/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
08/14/2007
PUBO
PUBLISHED FOR OPPOSITION
05/22/2007
NPUB
NOTICE OF PUBLICATION
05/02/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/27/2007
ALIE
ASSIGNED TO LIE
03/27/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2007
DOCK
ASSIGNED TO EXAMINER
02/28/2007
NWAP
NEW APPLICATION ENTERED
10/18/2006
Continuous trademark protection
Get notified about every new filing that threatens CANDEPRESSIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.